Aflatoxin Exposure in Human Populations: Measurements and Relationship to Cancer

References

• Perera F., Weinstein I. B. Molecular epidemiology and carcinogen DNA adduct detection: new approaches to studies of human cancer causation. J. Chronic Dis. 1982; 35: 581
   PubMedGoogle Scholar
• Busby W. F., Wogan G. N. Aflatoxins. Chemical Carcinogens, 2nd ed., C. E. Searle. American Chemical Society, Washington, D.C. 1985; 945
   Google Scholar
• Campbell A. A., Whitaker T. B., Pobland A. E., Dickens J. W., Park D. L. Sampling, sample preparation, and sampling plans for foodstuffs for mycotoxion analysis. Pure Appl. Chem. 1986; 58: 305
   Web of Science ®Google Scholar
• Stoloff L. Aflatoxin control—past and present. J. Assoc. Off. Anal. Chem. 1980; 63: 1067
   PubMedGoogle Scholar
• Cullen J. M., Ruebner B. H., Hseih L. S., Hyde D. M., Hseih D. P. Carcinogenicity of dietary aflatoxin Ml in male Fischer rats compared to aflatoxin B1. Cancer Res. 1987; 47: 1913
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Busby W. F., Donahue P. R., Wogan G. N. Aflatoxins as risk factors for liver cancer: an application of monoclonal antibodies to monitor human exposure. Biochemical and Molecular Epidemiology of Cancer, C. C. Harris. Alan R. Liss, New York 1986; 233
   Google Scholar
• National Cancer Office of the Ministry of Public Health, People's Republic of China. Studies on Mortality Rates of Cancer in China. People's Publishing House, Beijing 1980
   Google Scholar
• Alpert M. E., Hutt M. S. R., Davidson C. S. Hepatoma in Uganda: a study in geographic pathology. Lancet 1968; 1: 1265
   PubMed Web of Science ®Google Scholar
• Alpert M. E., Hutt M. S. R., Wogan G. N., Davidson C. S. Association between aflatoxin content of food and hepatoma in Uganda. Cancer 1971; 28: 253
   PubMed Web of Science ®Google Scholar
• Campbell T. C., Caedo J. P., Bulatao-Jayme J., Salamat L., Engel R. W. Aflatoxin M1 in human urine. Nature (London) 1970; 227: 403
   PubMed Web of Science ®Google Scholar
• Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer: a study in Swaziland. Int. J. Cancer 1976; 17: 167
   PubMed Web of Science ®Google Scholar
• Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer: a population based study in Kenya. Br. J. Cancer 1973; 27: 473
   PubMed Web of Science ®Google Scholar
• Shank R. C., Wogan G. N., Gibson J. B., Nondasuta A. Aflatoxins in market foods and foodstuffs of Thailand and Hong Kong. Food Cosmet. Toxicol. 1972; 10: 61
   Google Scholar
• Shank R. C., Gordon J. E., Wogan G. N., Nondasuta A., Subhamani B. Field survey of rural Thailand for ingested aflatoxins. Food Cosmet. Toxicol. 1972; 10: 71
   Google Scholar
• Van Rensburg S. J., van der Watt J. J., Purchase I. F. H., Coutinho L. P., Markham R. Primary liver cancer rate and aflatoxin intake in a high cancer area. S. Afr. Med. J. 1974; 48: 2508a
   PubMed Web of Science ®Google Scholar
• Shank R. C. Environmental Cancer, H. F. Kraybill, M. A. Mehlman. John Wiley & Sons, New York 1977; 291
   Google Scholar
• Linsell C. A., Peers F. G. Aflatoxin and liver cancer. Trans. R. Soc. Trap. Med. Hyg. 1977; 71: 471
   Google Scholar
• Bulatao-Jayme J., Almero E. M., Castro C. A., Jardeleza T. R., Salamat L. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int. J. Epidemiol. 1982; 11(2)112
   PubMed Web of Science ®Google Scholar
• Van Rensburg S. J., Cook-Mozaffari P., Van Schalkwyk D. J., Van der Watt J. J., Vincent T. J., Purchase I. F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 1985; 51: 713
   PubMed Web of Science ®Google Scholar
• Peers F., Bosch X., Kaldor J., Linsell A., Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer 1987; 39: 545
   PubMed Web of Science ®Google Scholar
• Autrup H., Bradley K. A., Shamsuddin A. K. M., Wakhisi J., Wasunna A. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7′-guanyl)-3-hydroxyaflatoxin B, in human urine collected in Murang'a district, Kenya. Carcinogenesis 1983; 4(9)1193
   PubMed Web of Science ®Google Scholar
• Autrup H., Seremet T., Wakhisi J., Wasunna A. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res. 1987; 47: 3430
   PubMed Web of Science ®Google Scholar
• Coulter J. B. S., Suliman G. I., Lamplugh S. M., Mukhtar B. I., Hendrickse R. G. Aflatoxins in liver biopsies from Sudanese children. Am. J. Trap. Med. Hyg. 1986; 35(2)360
   Google Scholar
• Wild C. P., Umbenhauer D., Chapot B., Montesano R. Monitoring of individual human exposure to aflatoxins (AF) and N-nitrosamines (NNO) by immunoassays. J. Cell. Biochem. 1986; 30: 171
   PubMed Web of Science ®Google Scholar
• Wild C. P., Pionneau F., Montesano R., Mutiro C. F., Chetsanga C. J. Afaltoxin detected in human breast milk by immunoassay. Int. J. Cancer 1987; 40: 328
   PubMed Web of Science ®Google Scholar
• Zhu J.-Q., Zhang L.-S., Hu X., Xiao Y., Chen J.-S., Xu Y.-C., Fremy J., Chu F. S. Correlation of dietary aflatoxin B, levels with excretion of aflatoxin M, in human urine. Cancer Res. 1987; 47: 1848
   PubMed Web of Science ®Google Scholar
• Yeh F.-S., Mo C.-C., Yen R.-C. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China. Nat. Cancer Inst. Monogr. 1985; 69: 47
   PubMedGoogle Scholar
• Tsuboi S., Nakagawa T., Tomita M., Soo T., Ono H., Kawamura K., Iwamura N. Detection of aflatoxin B1 in serum samples of male Japanese subjects by radioimmunoassay and high-peformance liquid chromatography. Cancer Res., 44: 1231
   PubMed Web of Science ®Google Scholar
• Sun T. T., Chu Y.-R., Hsia C.-C., Wei Y.-P., Wu S.-M. Strategies and current trends of etiologic prevention of liver cancer. Biochemical and Molecular Epidemiology, C. C. Harris. Alan R. Liss, New York 1986; 283
   Google Scholar
• Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr., Reinhold V. N., Buchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1in vitro. Proc. Natl. Acad. Sci. USA 1977; 74: 1870
   PubMed Web of Science ®Google Scholar
• Croy R. G., Essigmann J. M., Reinhold V. N., Wogan G. N. Identification of the principle aflatoxin B1-DNA adduct formedin vivo in rat liver. Proc. Natl. Acad. Sci. USA 1978; 75: 1745
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Busby W. F., Jr., Wogan G. N. Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liverin vivo. Cancer Res. 1980; 40: 4343
   PubMed Web of Science ®Google Scholar
• Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or-ribosomal RNA adducts formed in hepatic microsome mediated reactions in rat liverin vivo. Cancer Res. 1977; 37: 4430
   PubMed Web of Science ®Google Scholar
• Hertzog P. J., Lindsay Smith J. R., Garner R. C. Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B1-DNA, the persistent DNA adduct in vivo. Carcinogenesis 1982; 3: 723
   PubMed Web of Science ®Google Scholar
• Gopalan C., Tulpule P. G., Krishnamurthi D. Induction of hepatic carcinoma with aflatoxin in Rhesus monkey. Food Cosmet. Toxicol. 1972; 10: 519
   PubMedGoogle Scholar
• Adamson R. H., Correa P., Oalgard D. W. Brief communication: occurrence of a primary liver carcinoma in a Rhesus monkey fed aflatoxin B1. J. Natl. Cancer Inst. 1973; 50: 549
   PubMed Web of Science ®Google Scholar
• Tilak T. B. G. Induction of cholangiosarcoma following treatment of a Rhesus monkey with aflatoxin. Food Cosmet. Toxicol. 1975; 13: 247
   PubMedGoogle Scholar
• Sieber S. M., Correa P., Dalgard D. W., Adamson R. H. Introduction of ostrogenic sarcomas and tumors of the hepatobiliary system in non-human primates with aflatoxin B1. Cancer Res. 1979; 39: 4545
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Kensler T. W. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1. Pharmacol. Ther. 1987; 34: 321
   PubMed Web of Science ®Google Scholar
• McLean A. E. M., Marshall A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br. J. Exp. Pathol 1971; 52: 322
   Web of Science ®Google Scholar
• Gurtoo H. L., Koser P. L., Bansal S. K., Fox H. W., Sharma S. D., Mulhern A. I., Pavelic Z. P. Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by B-napthoflavone. Carcinogenesis 1985; 6: 675
   PubMed Web of Science ®Google Scholar
• Wong J. J., Hsieh D. P. H. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential. Proc. Natl. Acad. Sci. USA 1976; 73: 2241
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Dahms R. P., Paigen B. Metabolic activation of aflatoxins related to their mutagenicity. Biochem. Biophys. Res. Commun. 1975; 61: 735
   Google Scholar
• Cabral J. R. P., Neal G. E. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett. 1983; 9: 125
   Google Scholar
• Williams G. M., Tanaka T., Maeura Y. Dose-dependent inhibition of aflatoxin B1 induced-hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxytoluene and butylated hydroxyanisole. Carcinogenesis 1986; 7: 1043
   PubMed Web of Science ®Google Scholar
• DeLong M. J., Prochaska H. J., Talalay P. Inactivate electrophilic compounds. Protective Agents in Human and Experimental Cancer, D. C. McBrien, T. F. Slater. Academic Press, London, 175
   Google Scholar
• Kensler T. W., Egner P. A., Davidson N. E., Roebuck B. D., Pikul A., Groopman J. D. Modulation of aflatoxin metabolism, aflatoxinN7-guanine formation and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 1986; 46: 3924
   PubMed Web of Science ®Google Scholar
• Kensler T. W., Enger P. A., Trush M. A., Bueding E., Groopman J. D. Modification of aflatoxin B1 binding to DNAin vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis 1985; 6: 759
   PubMed Web of Science ®Google Scholar
• Croy R. G., Wogan G. N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981; 41: 197
   PubMed Web of Science ®Google Scholar
• Sabbioni G., Skipper P., Buchi G., Tannenbaum S. R. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B,in vivo in rats. Carcinogenesis 1987; 8: 819
   PubMed Web of Science ®Google Scholar
• Wild C. P., Garner R. G., Montesano R., Tursi F. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogensis 1986; 7: 853
   PubMed Web of Science ®Google Scholar
• Donahue P. R., Essigmann J. M., Wogan G. N. Aflatoxin-DNA adducts: detection in urine as a dosimeter of exposure. Banbury Rep. 1982; 13: 221
   Google Scholar
• Haugen A., Groopman J. D., Hsu I. C., Goodrich G. R., Wogan G. N., Harris C. C. Monoclonal antibody to aflatoxin B1 modified DNA detected by enzyme immunoassay. Proc. Natl. Acad. Sci. USA 1981; 78: 4124
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Haugen A., Goodrich G. R., Harris C. C. Quantitation of aflatoxin B1 modified DNA using monoclonal antibodies. Cancer Res. 1982; 42: 3120
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Trudel L. J., Donahue P. R., Rothstein A., Wogan G. N. High affinity monoclonal antibodies for aflatoxins and their application to solid phase immunoassay. Proc. Natl. Acad. Sci. USA 1984; 81: 7728
   PubMed Web of Science ®Google Scholar
• Pestka J. J., Chu F. S. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites. Appl. Environ. Microbiol 1982; 44: 1159
   PubMed Web of Science ®Google Scholar
• Sun T. T., Chu Y. Y. Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J. Cell. Physiol. Suppl. 1984; 3: 39
   PubMedGoogle Scholar
• Bennett R. A., Essigmann J. M., Wogan G. N. Excretion of an aflatoxin-guanine adduct in urine of aflatoxin B1-treated rats. Cancer Res. 1981; 41: 650
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Donahue P. R., Zhu J., Chen J., Wogan G. N. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA 1985; 82: 6492
   PubMed Web of Science ®Google Scholar
• Groopman J. D., Donahue P. R., Zhu J., Chen J., Wogan G. N. Temporal patterns of aflatoxin metabolites in urine of people living in Guangxi Province, PRC. Proc. Am. Assoc. Cancer Res. 1987; 28: 36
   Google Scholar